Showing results (811-820 of 3,353) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|November 3, 2023
Future cancer risk after urgent suspected cancer referral in England when cancer is not found: a national cohort studySuzanne E Scott, Carolynn Gildea, Brian D Nicholson, et al.
The Lancet. Oncology|November 10, 2023
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trialHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
The Lancet. Oncology|August 4, 2023
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer GroupsDavid Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, et al.
The Lancet. Oncology|August 4, 2023
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy studyKristina Lång, Viktoria Josefsson, Anna-Maria Larsson, et al.
The Lancet. Oncology|July 30, 2023
Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysisBella S Ehrlich, Michael J McNeil, Linh T D Pham, et al.
The Lancet. Oncology|September 1, 2023
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
The Lancet. Oncology|June 3, 2023
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and proceduresMadeline Pe, Ahu Alanya, Ragnhild Sorum Falk, et al.
The Lancet. Oncology|June 3, 2023
Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investmentsStuart A McIntosh, Fareeha Alam, Laura Adams, et al.
The Lancet. Oncology|October 5, 2023
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trialXiangyu Gao, Nong Xu, Ziyu Li, et al.
The Lancet. Oncology|October 5, 2023
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statementWanda Cui, Rodney P Rocconi, Ramya Thota, et al.
Pageof 336